OPTOCIRCUI

HSBC Global Asset Management (Singapore) Limited has submitted to the Exchange vide letter dated February 21, 2013 a copy of Disclosure in terms of Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Opto Circuits (India) Limited has submitted to the Exchange vide its letter dated February 05, 2013 a copy of Disclosure under Regulation 13(1) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Opto Circuits (India) Limited has informed the Exchange vide letter dated February 05, 2013 that none of the Promoters shares have ever been pledged.

Jupiter Asset Management Limited has submitted to the Exchange vide letter dated February 04, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of Disclosure under Regulation 13(1) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Spurt in Volume : Substantial increase in trading volumes have been observed in Opto Circuits (India) Limited.. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Opto Circuits (India) Limited has vide its letter inter-alia stated, "We would like to inform you that, there is no information/announcement (including impending announcement) which in our opinion may have a bearing on the price/volume behavior of the scrip."

Opto Circuits (India) Limited has informed the Exchange that Mr. Srinatha A N has been transferred to Opto Circuits (India) Limited ('OCIL') from Opto Eurocor Healthcare Limited ( subsidiary of OCIL ) as Company Secretary and Compliance Officer in place of Mr. K.V. Ganesh.

Opto Circuits (India) Limited has informed the Exchange that the Board of Directors of the Company at their meeting held on December 20, 2012 has approved the following subject to satisfactory receipt of all statutory, regulatory, corporate and other approvals including shareholders through Postal Ballot, as may be required: (1) To issue 20,00,000 convertible warrants to Mr. Vinod Ramnani at Rs. 145/- per convertible warrant or as per the pricing formula as stipulated in SEBI's (ICDR) Regulations 2009, whichever is higher.

Opto Circuits (India) Limited has informed the Exchange that the Company has secured BBB+ (pronounced 'BWR Triple B Plus') rating from Brickworks Ratings India Pvt. Ltd. for its fund based working capital facilities. The rating indicates as stable outlook.

Opto Circuits (India) Limited has submitted to the Exchange the Standalone and Consolidated Financial Results for the period ended September 30,2012.

Opto Circuits (India) Limited has informed the Exchange regarding the Outcome of the Annual General Meeting of the Company held on September 29, 2012.

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated September 20, 2012 titled "Unetixs Vascular Inc., an Opto Circuits Group Company Receives CE Certification for Revo 1100".

Opto Circuits (India) Limited has submitted to the Exchange vide letter dated September 07, 2012 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of Disclosure under Regulation 13(1) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

HSBC Global Asset Management (Singapore) Limited has submitted to the Exchange vide letter dated September 10, 2012 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated September 10, 2012 titled "Opto Circuits launches its first Sirolimus Drug Eluting Stent".

Opto Circuits (India) Limited has informed the Exchange that the Register of Members and the Share Transfer Books of the Company will be closed from September 25, 2012 to September 29, 2012 (both days inclusive) for the purpose of payment of dividend. The Annual General Meeting of the Company will be held on September 29, 2012.

Opto Circuits (India) Limited has informed the Exchange that the Company has appointed CRISIL on July 04, 2012 to rate the credit facilities of the Company.

Opto Circuits (India) Limited has informed the Exchange regarding the standalone Results for the quarter ended on 30-JUN-2012 as follows: Net Sales of Rs. 18910.97 lacs for quarter ending on 30-JUN-2012. Net Profit / (Loss) of Rs. 6278.74 lacs for the quarter ending on 30-JUN-2012.

Opto Circuits (India) Limited has submitted to the Exchange the Standalone Financial Results for the period ended June 30,2012.

Opto Circuits (India) Limited has submitted to the Exchange the Consolidated Financial Results for the period ended June 30,2012.

Opto Circuits (India) Limited has informed the Exchange regarding the consolidated Results for the quarter ended on 30-JUN-2012 as follows: Net Sales of Rs. 71506.07 lacs for quarter ending on 30-JUN-2012. Net Profit / (Loss) of Rs. 13801.69 lacs for the quarter ending on 30-JUN-2012.

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated June 11, 2012, titled "Opto Circuits launches new Powerheart G5 AED".

Opto Circuits (India) Limited has informed the Exchange that the Board of Directors of the Company at its Meeting held on May 22, 2012 has recommended dividend of Rs.3.00 per share on Equity Shares of Rs.10 each of the Company subject to the approval of the share holders in the Annual General Meeting.

Opto Circuits (India) Limited has submitted to the Exchange the Consolidated Financial Results for the period ended March 31,2012.

Opto Circuits (India) Limited has informed the Exchange regarding the consolidated Results for the year ended on 31-MAR-2012 as follows: Net Sales of Rs. 235685.43 lacs for year ending on 31-MAR-2012 against Rs. 158556.31 lacs for the year ending on 31-MAR-2011. Net Profit / (Loss) of Rs. 57187.95 lacs for the year ending on 31-MAR-2012 against Rs. 36720.59 lacs for the year ending on 31-MAR-2011.

Opto Circuits (India) Limited has submitted to the Exchange the Standalone Financial Results for the period ended March 31,2012.

Opto Circuits (India) Limited has informed the Exchange that Mr. K.V Ganesh has been appointed as Company Secretary and Compliance officer of the Company in place of Mr. Srinath A N, who has been appointed as Company Secretary of Opto Eurocor Healthcare Limited a subsidiary company of Opto Circuits (India) Limited.

Opto Circuits (India) Limited has informed the Exchange that the Record Date for the purpose of issue of bonus shares in the ratio of 3:10 (Three Bonus Shares for every 10 Shares held) as approved by the shareholders through postal ballot is fixed on March 31, 2012.

Opto Circuits (India) Limited has informed the Exchange vide its letter dated March 20, 2012 regarding passing of the Resolution through postal ballot.

Opto Circuits (India) Limited has submitted to the Exchange a copy of Notice pursuant to Section 192A of the Companies Act, 1956, read with the Companies (Passing of the Resolution by Postal Ballot) Rules, 2011 sent for approval by the shareholders on the following items: (1) Increase of Authorised Share Capital of the Company. (2) Alteration of the Memorandum of Association. (3) Alteration of the Articles of Association. (4) Issue of Bonus Share to Equity Shareholders.

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated February 13, 2012, titled "Eurocor GmbH announces presentation of Valentines Trial II results at CRT2012".

Opto Circuits (India) Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on February 07, 2012 have recommended Three equity Bonus shares for every Ten fully paid equity shares, subject to the approval of the shareholders.

Opto Circuits (India) Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-DEC-2011 as follows: Net Sales of Rs. 17053.64 lacs for quarter ending on 31-DEC-2011 against Rs. 16267.44 lacs for the quarter ending on 30-SEP-2011. Net Profit / (Loss) of Rs. 6041.12 lacs for the quarter ending on 31-DEC-2011 against Rs. 5759.92 lacs for the quarter ending on 30-SEP-2011.

Opto Circuits (India) Limited has submitted to the Exchange the Standalone and Consolidated Financial Results for the period ended December 31,2011.

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated February 02, 2012, titled "Cardiac Science AEDs now available for Airbus aircraft".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated January 17, 2012, titled "Opto Circuits' subsidiary Criticare Secures a Contract to Supply nGenuity Vital Signs Monitors to Russian Hospitals".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated January 04, 2012, titled "Opto Circuits' subsidiary Cardiac Science receives FDA Clearance for MySense Heart".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated December 13, 2011, titled "500 clubs in Victoria to be equipped with Cardiac Science Powerheart(R) AEDs".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated November 14, 2011, titled "Opto Circuits' Powerheart(R) AEDs to Combat Sudden Cardiac Arrest at Hong Kong Department of Health".

Opto Circuits (India) Limited has submitted to the Exchange the Consolidated Financial Results for the period ended September 30,2011.

Opto Circuits (India) Limited has submitted to the Exchange the Standalone Financial Results for the period ended September 30,2011.

Opto Circuits (India) Limited has informed the Exchange regarding the Outcome of the Annual General Meeting of the Company held on September 28, 2011.

Opto Circuits (India) Limited has submitted to the Exchange a copy of the Notice of the Annual General Meeting of the Members of the Company to be held on September 28, 2011.

Opto Circuits (India) Limited has informed the Exchange that OPTO EUROCOR HEALTHCARE LTD., wholly owned subsidiary of the Company proposes to raise upto Rs.1000.00 crores through Initial Public Offering.

Opto Circuits (India) Limited has informed the Exchange that the Company has been featured in Forbes Asia's 200 'Best Under a Billion' List, 2011. This is the third time the Company have made it to this list, the last two times being 2008 and 2009.

Opto Circuits (India) Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on August 22, 2011 has approved the following : (1) Directors Report, Notice of Annual General Meeting to be held on September 28, 2011; (2) To increase the Foreign Financial Institutions (FII) limit of existing 40% to 49% in the company's paid up capital subject to the approval of Shareholders.

Opto Circuits (India) Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on August 22, 2011 has approved to increase the Foreign Financial Institutions (FII) limit of existing 40% to 49% in the company's paid up capital subject to the approval of the shareholders.

Opto Circuits (India) Limited has informed the Exchange that the Register of Members and the Share Transfer Books of the Company will be closed from September 23, 2011 to September 28, 2011 (both days inclusive) for the purpose of payment of dividend. The Annual General Meeting of the Company will be held on September 28, 2011.

Opto Circuits (India) Limited has submitted to the Exchange the Standalone Financial Results for the period ended June 30,2011.

Opto Circuits (India) Limited has submitted to the Exchange the Consolidated Financial Results for the period ended June 30,2011.

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated July 08, 2011, titled" Opto Circuits' Company Cardiac Science re-enters Japanese market for AEDs with an exclusive sales agreement with Omron Healthcare".